CAJ | 학술논문

目的：探讨术前肠内营养支持对胃肠道肿瘤患者围手术期作用的影响。方法：选择2009年10月～2012年10月收治入院胃肠道肿瘤患者100例临床资料进行回顾性分析，将采用传统肠内营养支持法50例患者作为对照组；将传统肠内营养基础上术前口服能全力肠内营养支持的50例作为观察组。所有患者均于术前1d及术后第8天测量体重，抽取静脉血测定血红蛋白及血清白蛋白含量，并于第8天留取患者24h尿测定尿素氮，计算氮平衡。结果：两组免疫、营养指标肠道准备前与术后差异相比较有统计学意义(P<0.05)；对照组术后各免疫、营养指标较肠道准备前有显著下降(P<0.01)；血红蛋白、血清白蛋白含量及氮平衡比较，观察组明显优于对照组，差异有统计学意义(P<0.05)。结论：术前肠内营养支持能明显改善胃肠道肿瘤患者围手术期的营养状况。
목적：탐토술전장내영양지지대위장도종류환자위수술기작용적영향。방법：선택2009년10월～2012년10월수치입원위장도종류환자100례림상자료진행회고성분석，장채용전통장내영양지지법50례환자작위대조조；장전통장내영양기출상술전구복능전력장내영양지지적50례작위관찰조。소유환자균우술전1d급술후제8천측량체중，추취정맥혈측정혈홍단백급혈청백단백함량，병우제8천류취환자24h뇨측정뇨소담，계산담평형。결과：량조면역、영양지표장도준비전여술후차이상비교유통계학의의(P<0.05)；대조조술후각면역、영양지표교장도준비전유현저하강(P<0.01)；혈홍단백、혈청백단백함량급담평형비교，관찰조명현우우대조조，차이유통계학의의(P<0.05)。결론：술전장내영양지지능명현개선위장도종류환자위수술기적영양상황。
Objective:To investigate the influence of preoperative enteral nutrition on patients with gastrointestinal cancer during the perioperative period. Methods:Clinical data of 100 cases of patients with gastrointestinal cancer hospitalized from october 2009 to october 2012 were retrospectively analyzed. 50 cases in each group. The control group was given traditional enteral nutritional support method, the test group was given nutrison enteral nutrition on the basis of control group. The patients' body weight were measured and peripheral blood was taken and inspecting hemoglobin and serum albumin levels on the first and the eighth preoperative and postoperative days. The urea nitrogen level from patients 24 h urinary specimens on the eighth postoperative was measured, and then calculate the nitrogen balance. Results:The immunization and nutrition indicators of the two groups were significant different before bowel preparation and postoperative (P<0.05). The postoperative immunization and nutrition indicators of control group were significant decreased (P<0.01). The levels of hemoglobin and serum albumin and nitrogen balance were significantly different between the two groups, the test group was more better than the control group (P<0.05). Conclusion:Preoperative enteral nutrition can improve the nutriture of the patients with gastrointestinal cancer during the perioperative period.